MYC and neoplasm: Targeting MCTs/Basigin complexes was reported to impair the in vitro and in vivo growth of pancreatic tumor cells, Ras-transformed fibroblasts, colon adenocarcinoma, and Myc-induced human malignancies, suggesting that blocking lactic acid export provides an efficient metabolic therapy to limit tumor cell growth [41].